Aurinia Pharmaceuticals Inc (AUPH)

03:36 AM

Millennium Management LLC Increases Stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

03:36 AM

Jun 06, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SDIG, AUPH and LICY - ACCESS Newswire

Jun 06, 2025

Jun 06, 2025

(AUPH) Trading Signals - news.stocktradersdaily.com

Jun 06, 2025

Jun 06, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.27 Million Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - InsuranceNewsNet

Jun 06, 2025

Jun 06, 2025

Ameriprise Financial Inc. Acquires 26,981 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 06, 2025

Jun 03, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AUPH, IRNT and RSKD - ACCESS Newswire

Jun 03, 2025

May 31, 2025

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? - MSN

May 31, 2025

May 31, 2025

BNP Paribas Financial Markets Sells 14,003 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 31, 2025

May 30, 2025

Is The Options Market Predicting A Spike In Aurinia Pharmaceuticals (AUPH) Stock? - Barchart.com

May 30, 2025

May 28, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 28, 2025

May 27, 2025

Nuveen Asset Management LLC Increases Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 27, 2025

May 27, 2025

Cetera Investment Advisers Purchases 2,000 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 27, 2025

May 27, 2025

(AUPH) Technical Data - news.stocktradersdaily.com

May 27, 2025

May 26, 2025

Deutsche Bank AG Purchases 50,575 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 26, 2025

May 22, 2025

Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial R - GuruFocus

May 22, 2025

May 22, 2025

Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial Results | AUPH Stock News - GuruFocus

May 22, 2025

May 22, 2025

Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study - TipRanks

May 22, 2025

May 19, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st

May 19, 2025

May 19, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

May 19, 2025

May 16, 2025

Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 16, 2025

May 16, 2025

Leerink Partnrs Has Positive Outlook of AUPH Q2 Earnings - Defense World

May 16, 2025

May 15, 2025

Aurinia Pharmaceuticals Approves New Equity Incentive Plan - TipRanks

May 15, 2025

May 15, 2025

Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

May 15, 2025

May 15, 2025

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025

May 15, 2025

Transcript : Aurinia Pharmaceuticals Inc.Shareholder/Analyst Call - marketscreener.com

May 15, 2025

May 14, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - MSN

May 14, 2025

May 14, 2025

Aurinia Pharmaceuticals Financial Update and Strategic Growth Plans - Zenopa

May 14, 2025

May 14, 2025

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

May 14, 2025

May 14, 2025

Price T Rowe Associates Inc. MD Has $468,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 14, 2025

May 13, 2025

Aurinia outlines $250M–$260M 2025 revenue target as LUPKYNIS sales climb 25% and operational efficiency improves - MSN

May 13, 2025

May 13, 2025

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

May 13, 2025

May 12, 2025

Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 12, 2025

May 12, 2025

Document - SEC.gov

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks

May 12, 2025

May 12, 2025

Aurinia: Q1 Earnings Snapshot - MySA

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025

May 12, 2025

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga

May 12, 2025

May 12, 2025

Leerink maintains Aurinia stock Outperform with $10 target - Investing.com

May 12, 2025

May 12, 2025

Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens - Investing.com India

May 12, 2025

May 12, 2025

AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals' Q1 Swings to Profit, Revenue Rises; Reiterates 2025 Revenue Guidance - marketscreener.com

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Inc. Reiterates Guidance for the Full Year 2025 - marketscreener.com

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks

May 12, 2025

May 12, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire

May 12, 2025

May 09, 2025

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

May 09, 2025

May 06, 2025

How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com

May 06, 2025

May 05, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - BioSpace

May 05, 2025